ProPhase Labs, Inc. (OTC: PRPH) today provided an update to shareholders regarding recent trading activity, its capital structure, and the Company’s underlying asset base. The Company believes that ...

An update from Prophase Labs ( ($PRPH) ) is now available. On December 29, 2025, ProPhase Labs, Inc. disclosed that it had failed to regain ...

Proposed transaction aims to deliver near-term value for ProPhase shareholders, long-term growth for ABL, and create a global, innovation-driven company. Company to hold a virtual conference call ...

Detailed price information for Prophase Labs Inc (PRPH-Q) from The Globe and Mail including charting and trades.

Ted Karkus, Chairman & CEO, opened by emphasizing the critical importance of shareholder voting on the company's proxy, noting, "If you do not vote for our proxy, you are putting our company in harm's ...

The latest finance and stock market news covering the Dow, S&P 500, banking, investing and regulation.

ProPhase Labs has put a diagnostic-testing unit into bankruptcy, a move it has been planning as a way to collect on millions of dollars in accounts receivables from its days processing Covid-19 tests ...

Prophase Labs ((PRPH)) has held its Q2 earnings call. Read on for the main highlights of the call. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and ...

ProPhase Labs Inc. (PRPH) reported its second-quarter earnings for 2025, showcasing a narrower-than-expected loss but significant revenue shortfall. The company posted an earnings per share (EPS) of ...

ProPhase Labs received a 180-day extension from Nasdaq to meet its $1.00 bid price compliance requirement. ProPhase Labs Inc. announced that it has received a 180-day extension from Nasdaq to meet the ...

ProPhase Labs Inc. (PRPH) reported its first-quarter 2025 earnings, posting an earnings per share (EPS) of -0.13, surpassing analysts’ expectations of -0.18. Despite a significant revenue miss, the ...